Private clinic growth

Advertising botulinum toxin: ASA and MHRA rules

What clinics can and cannot say when advertising botulinum toxin under CAP rule 12.12: social media, websites, landing pages, models and safe wording.

Ava research teamPublished 6 min read

On this page
  1. The rule in plain words
  2. What you can and cannot say
  3. Social media: where most breaches happen
  4. Websites and landing pages
  5. Models, influencers and endorsements
  6. Weight-loss and other prescription-only treatments
  7. What happens when it goes wrong
  8. Safe ways to market an aesthetics clinic
  9. A pre-publication check
  10. Training the people who post
  11. Example: cleaning up a clinic's Instagram
  12. Frequently asked questions
  13. References

Key takeaways

  • Botulinum toxin is a prescription-only medicine, and CAP rule 12.12 bans advertising it to the public in every non-broadcast medium, including search and social ads.
  • The ASA treats almost any reference to a prescription-only medicine as promotion, including implied references through images, hashtags or landing pages.
  • Promote the consultation for the area of concern, not the medicine, and drop before and after photos and professional endorsements for these treatments.
  • Run every post, ad and page through a short pre-publication check, and train everyone who posts for the clinic.

The rule in plain words

Botulinum toxin injections, sold under brand names such as Botox, are prescription-only medicines and cannot be advertised to the public, including on social media[1]. The rule that applies is CAP Code rule 12.12, and its ban covers Google sponsored search ads and social media ads as well as print[2]. It applies to leaflets, posters, press ads, websites and anything else you publish, in every non-broadcast medium[2].

The test is wide. The ASA considers almost every reference to a prescription-only medicine to be a promotion of it and a clear breach of rule 12.12[3]. Naming the product is the obvious breach, but references can also be implied through descriptions, imagery such as injection pens, or a combination of signals[3].

What you can and cannot say

Common wording problems in botulinum toxin marketing and compliant alternatives.
AvoidUse instead
Brand or generic names of the toxin'A consultation to discuss lines and wrinkles'
'Anti-wrinkle injections', 'tox', 'baby botox''Book a consultation with our nurse prescriber'
Prices or offers for toxin treatmentThe consultation fee, if you charge one
Images of syringes, vials or injection pensImages of your clinic, team or consultation room
Before and after photographs of toxin resultsInformation about how consultations work
Hashtags naming the medicineHashtags about your clinic name or location
Endorsements by doctors, nurses or influencersFactual qualifications listed on your team page

The principle behind the right-hand column comes from CAP's own advice: a reference to a consultation on the area of treatment is likely to be acceptable, provided it is representative of the medicine's licence and the medicine itself is not referred to directly or indirectly[3].

Social media: where most breaches happen

CAP and the ASA have seen a rise in social media posts for prescription-only products, and any reference to them on a business's social pages, including images and hashtags, is likely to be treated as an implied ad[3]. CAP's Compliance team has issued enforcement notices on social media posts for Botox and other prescription-only medicines[3].

  • Your own posts, stories, reels and highlights all count, not only paid ads.
  • Reposting a client's post that names the medicine makes it your advertising.
  • Hashtags and captions can create a breach even when the image is neutral.
  • Old posts stay live; review your archive, not just new content.
  • Comments and replies on public posts are part of the page; move product questions into private conversation and talk about consultations.

Websites and landing pages

There are some allowances for a marketer's own website, but the ban still applies to the homepage, and where references to a prescription-only medicine are permitted elsewhere on the site, they must be balanced and factual rather than promotional[3]. That usually means a treatment information page written like patient information: what the treatment involves, who it may not suit, risks and the need for a consultation, without prices, offers or results photos.

Landing pages matter as well. Even if a digital ad itself is compliant, linking it directly to website content that promotes a prescription-only medicine may still breach the Code[3]. Point ads at a page about consultations, not at a treatment page with prices.

Models, influencers and endorsements

Ads asking for models for treatments in general terms are likely to be acceptable, but if they refer to modelling for a prescription-only treatment they are likely to breach the Code, because the ad is still seen by the public[3]. Using health professionals or celebrities to endorse any medicine breaches rule 12.18, and CAP notes that an influencer with a large following can count as a celebrity for this purpose[3].

Before and after photographs are likely to be treated as an advertising claim, which is not permitted for prescription-only medicines[3]. Testimonials raise a separate issue under consumer law: fake reviews and concealed incentivised reviews are a banned practice[4], so never reward clients for reviews and never post reviews you cannot verify.

Weight-loss and other prescription-only treatments

The same rules apply to every prescription-only medicine a clinic offers. As many as 1.5 million people in the UK are estimated to be taking GLP-1 weight-loss medicines through private prescriptions[5], and the ASA has ruled against ads that promoted this class of medicines without naming a brand, by referring to 'GLP-1', 'weight loss injection' and showing an injection pen[3]. Other prescription-only treatments the ASA has looked at include vitamin B12 injections, hyaluronidase, steroid injections and sclerotherapy[3].

UK adults and private healthcare
UK adults and private healthcareComparison. Have used private healthcare: 34%; Expect to use it in the next 12 months: 40%.34%Have used private healthcareHave used private healthcare: 34%40%Expect to use it in the next 12 monthsExpect to use it in the next 12 months: 40%UK adults and private healthcareComparison. Have used private healthcare: 34%; Expect to use it in the next 12 months: 40%.34%Have used private healthcareHave used private healthcare: 34%40%Expect to use it in the next 12monthsExpect to use it in the next 12 months: 40%

Source: Independent Healthcare Providers Network (IHPN), 2026[6]

Show the data
ItemValue
Have used private healthcare34%
Expect to use it in the next 12 months40%

The size of the private healthcare audience is one reason regulators watch this area closely: a third of people have used private healthcare and 40% expect to in the next year[6], so clinic advertising reaches a large and often young audience.

What happens when it goes wrong

Breaches usually come to light through a complaint from a member of the public, a competitor or the regulator's own monitoring. The ASA publishes its rulings with the advertiser's name, and CAP's Compliance team uses enforcement notices for sectors where breaches are widespread[3]. A published ruling is a reputational problem in itself, because it appears in searches for your clinic's name.

Professional regulators can become involved too. Many aesthetic practitioners are dentists, doctors, nurses or pharmacists. For dental professionals, the GDC says misleading advertising is unprofessional, may lead to a fitness to practise investigation and can be a criminal offence[7]. Treat advertising compliance as part of professional practice, not only as a marketing matter.

Safe ways to market an aesthetics clinic

  • Promote consultations, with a clear explanation of what happens at one and who carries it out.
  • Show your clinic, team and qualifications, without endorsing any medicine.
  • Publish educational content about skin health and ageing that does not point to a prescription-only product.
  • Advertise treatments that are not prescription-only on their own merits, with accurate claims.
  • Encourage genuine reviews about the experience, without incentives.
  • Make it easy to book a consultation online or by phone.

Advertising to professionals is treated differently: prescription-only medicines can likely be advertised to the medical, dental and allied professions, provided the ads are not also directed at the public[3]. A clinic's public Instagram account is not a professional channel.

A pre-publication check

  1. Read it as a member of the public

    Would a reasonable person understand the post or ad to be about a prescription-only medicine?

  2. Check words, images and hashtags

    Remove product names, nicknames, injection imagery and hashtags that point to the medicine.

  3. Check where it links

    Make sure any link lands on a consultation page, not a promotional treatment page.

  4. Check people

    No health professional or influencer endorsing a medicine, and no before and after images for these treatments.

  5. Record the sign-off

    Keep a simple log of who approved each campaign and when; it helps if you are asked to explain.

Training the people who post

In many clinics, social media is run by whoever has time: a receptionist, a nurse, a family member or an agency. Each of them needs the same short briefing. Cover the core rule, the list of words and images to avoid, how to answer public comments, where ads should link and who signs off campaigns. Repeat it when someone new starts posting and when the clinic adds a new treatment.

  • Give the posting guide to any agency in writing and make compliance part of the contract.
  • Keep a shared folder of approved images and captions.
  • Review the account monthly for old posts, highlights and hashtags.

Example: cleaning up a clinic's Instagram

Example (fictional): a dental practice in Chester that also offers facial aesthetics reviewed its Instagram account after a competitor received a complaint. It archived 70 old posts that named toxin brands or showed syringes, removed product hashtags from its bio and highlights, replaced its 'tox price list' story with a consultation explainer, and redirected its paid ads to a consultation booking page. It also wrote a one-page posting guide for the two nurses who managed the account. Enquiries continued at a similar level, and now arrived as consultation requests rather than price questions.

Frequently asked questions

Can a clinic advertise Botox on Instagram?

No. Botulinum toxin is a prescription-only medicine and cannot be advertised to the public, including on social media. Promote a consultation for the area of concern instead.

Can we say 'anti-wrinkle injections' instead of Botox?

It is likely to be treated as an indirect reference to a prescription-only medicine. Talk about a consultation for lines and wrinkles without naming or implying the product.

Are before and after photos allowed for toxin treatments?

CAP advises they are likely to be treated as an advertising claim, which is not permitted for prescription-only medicines.

Can we mention Botox anywhere on our website?

Not on the homepage. Elsewhere, any reference must be balanced and factual rather than promotional, without prices, offers or results photos.

References

  1. Advertising Standards Authority (ASA) / CAP (2026). Enforcement Notice: Advertising Botox and other botulinum toxin injections on social media (opens in a new tab) ↑

  2. Advertising Standards Authority (ASA) / CAP (2026). Healthcare: Prescription-only medicine (opens in a new tab) ↑

  3. Advertising Standards Authority (ASA) / CAP (2026). Healthcare: Prescription-only medicine (opens in a new tab) ↑

  4. Competition and Markets Authority (2025). Fake reviews: guidance on the banned practice (CMA208) (opens in a new tab) ↑

  5. GOV.UK (Department of Health and Social Care) (2025). Fit for the future: 10 Year Health Plan for England (opens in a new tab) ↑

  6. Independent Healthcare Providers Network (IHPN) (2026). Support for using private healthcare now found across the political spectrum, new report shows (opens in a new tab) ↑

  7. General Dental Council (2026). Guidance on advertising (opens in a new tab) ↑

Book a demo

See Ava handle your calls.

Book a short demo. We’ll walk through your calls and workflow, and agree what Ava should take care of.

Book a demo